Press "Enter" to skip to content

Bridge Biotherapeutics Announces Data Presentation from First-in-Human Study of BBT-877 for Idiopathic Pulmonary Fibrosis – Yahoo Finance

admin 0

Bridge Biotherapeutics Announces Data Presentation from First-in-Human Study of BBT-877 for Idiopathic Pulmonary Fibrosis  Yahoo Finance

Postive Interim Results from Ongoing Phase 1 Trial Presented at ATS 2019 SEONGNAM, South Korea and DALLAS , May 20, 2019 /PRNewswire/ — Bridge …

“lung cancer” – Google News

(Visited 8 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *